市場調査レポート
商品コード
1035574

解剖病理学の世界市場 - 2026年までの予測:製品・サービス別 (計器、消耗品)、用途別 (疾患診断、医学研究)、エンドユーザー別、地域別

Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User(Hospital Laboratories), Region - Global Forecasts -2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 325 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
解剖病理学の世界市場 - 2026年までの予測:製品・サービス別 (計器、消耗品)、用途別 (疾患診断、医学研究)、エンドユーザー別、地域別
出版日: 2021年11月02日
発行: MarketsandMarkets
ページ情報: 英文 325 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の解剖病理学の市場規模は、2021年の351億米ドルから、2026年までに491億米ドルに達し、CAGRで7.0%の成長が予測されています。

解剖病理学市場の成長は、がんやその他の対象疾患の高い発生率、がん検診の推奨、償還の利用可能性、個別化医療への注目の高まりなどが主な要因となっています。さらに、中国、インド、ブラジルなどの新興国が、予測期間中に市場で操業中の企業に大幅な成長機会を提供すると予想されています。

当レポートでは、世界の解剖病理学市場について調査分析し、市場概要、業界動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 機会
    • 課題
    • 動向
    • 解剖病理学市場に対するCOVID-19の影響
  • 顧客のビジネスに影響を与える動向/ディスラプション
  • 範囲/シナリオ
  • 価格分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • 技術分析
  • 規制情勢
  • 特許分析
  • 貿易分析
  • ポーターのファイブフォース分析

第6章 解剖病理学市場:製品・サービス別

  • サービス
  • 消耗品
  • 計器

第7章 解剖病理学市場:用途別

  • 疾患診断
  • 医学研究

第8章 解剖病理学市場:エンドユーザー別

  • 病院研究所
  • 臨床検査室
  • その他

第9章 解剖病理学市場:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • その他のアジア太平洋地域
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要企業の戦略
  • 主要な市場企業 (計器・消耗品) の収益シェア分析
  • 市場シェア分析 (計器・消耗品)
  • 企業の評価象限
  • 企業の評価象限:中小企業/スタートアップ
  • 競合シナリオ
  • 競合ベンチマーキング

第11章 企業プロファイル

  • 主要企業
    • F. HOFFMAN-LA ROCHE LTD.
    • DANAHER CORPORATION
    • PHC HOLDINGS CORPORATION
    • ABCAM PLC.
    • HOLOGIC, INC.
    • AGILENT TECHNOLOGIES
    • BECTON, DICKINSON AND COMPANY
    • SAKURA FINETEK USA INC.
    • MERCK KGAA
    • BIO SB
  • その他の企業
    • BIOGENEX
    • MILESTONE MEDICAL
    • HISTO-LINE LABORATORIES
    • DIAPATH S.P.A.
    • SLEE MEDICAL GMBH
    • AMOS SCIENTIFIC PTY LTD.
    • MEDITE MEDICAL GMBH
    • CELL SIGNALING TECHNOLOGY
    • CELLPATH LTD.
    • JINHUA YIDI MEDICAL APPLIANCE CO. LTD.
    • MICROS AUSTRIA
    • R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED
    • LUPETEC
    • MEDIMEAS
    • BRIGHT INSTRUMENTS

第12章 付録

目次
Product Code: MD 5104

The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period.

"The anatomic pathology services segment accounted for the highest growth rate in the anatomic pathology market, by product and service, during the forecast period"

Based on product & service, the anatomic pathology market is segmented into services, consumables, and instruments. The anatomic pathology services segment is projected to register the highest CAGR during the forecast period. The growth of this segment is primarily driven by rapid growing geriatric population and the increasing incidence of cancer and other chronic diseases.

"Disease Diagnostics accounted for the highest CAGR"

Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment is projected to register the highest CAGR during the forecast period. This can be attributed to rising geriatric population and the increasing incidence of cancer and other chronic diseases.

"Hospital laboratories accounted for the highest CAGR"

Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. Hospital laboratories is projected to register the highest CAGR during the forecast period. Increasing number of patient visits to hospitals, the growing number of in-house diagnostic procedures performed in hospitals, and growing awareness regarding early disease diagnosis are major factors contributing to growth of the segment.

"Asia Pacific: The fastest-growing region in the Anatomic pathology market"

The anatomic pathology market is segmented into North America, Europe, Asia Pacific, and Rest of the World. The Asia Pacific region offers high-growth opportunities for players in the anatomic pathology market. The presence of emerging economies like China and India, the large population in APAC countries, rising prevalence of chronic diseases, improving standard of living, growing demand for quality medical care, increasing healthcare spending and government initiatives, and rising awareness about the use of anatomic pathology tests among physicians are the major factors driving market growth in the Asia Pacific region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 28%, Tier 2 - 42%, and Tier 3 - 30%
  • By Designation: C-level - 30%, D-level - 34%, and Others - 36%
  • By Region: North America- 46%, Europe- 25%, Asia Pacific - 18%, RoW - 11%

Lists of Companies Profiled in the Report:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • PHC Holdings Corporation (Japan)
  • Becton, Dickinson and Company (US)
  • Abcam plc (UK)
  • Agilent Technologies, Inc. (US)
  • Hologic, Inc. (US)
  • Merck KGaA (Germany)
  • Bio SB (US)
  • Diapath S.p.A. (Italy)
  • Histo-Line Laboratories (Italy)
  • Milestone Medical (Italy)
  • SLEE medical GmbH (Germany)
  • BioGenex (US)
  • Sakura Finetek (US)
  • Amos Scientific Pty Ltd. (Australia)
  • MEDITE Medical GmbH (Germany)
  • Cell Signaling Technology, Inc. (US)
  • CellPath Ltd. (UK)
  • Jinhua Yidi Medical Equipment Co., Ltd. (China)
  • MICROS AUSTRIA (Austria)
  • R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED (India)
  • Lupetec (Brazil)
  • Medimeas (India)
  • Bright Instruments (UK)

Research Coverage:

This report provides a detailed picture of the anatomic pathology market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall anatomic pathology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, opportunities, challenges, and trends.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 ANATOMIC PATHOLOGY MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (ANATOMIC PATHOLOGY MARKET)
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 APPROACH 1: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
      • 2.2.1.1 Bottom-up approach for the instruments and consumables market
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.2 APPROACH 2: SECONDARY DATA & PRIMARY INTERVIEWS
    • 2.2.3 APPROACH 3: TOP-DOWN APPROACH
    • FIGURE 6 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
      • 2.2.3.1 Services market estimation based on the number of tests
      • 2.2.3.2 Services market estimation based on procedures
    • FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS IN THE ANATOMIC PATHOLOGY MARKET (2021-2026)
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: ANATOMIC PATHOLOGY MARKET
    • 2.6.1 COVID-19 SPECIFIC ASSUMPTIONS
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 GROWTH RATE ASSUMPTIONS
  • 2.9 COVID-19 ECONOMIC ASSESSMENT
  • 2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

    • FIGURE 12 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 ANATOMIC PATHOLOGY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 ANATOMIC PATHOLOGY MARKET: REGIONAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 ANATOMIC PATHOLOGY MARKET OVERVIEW
    • FIGURE 18 HIGH INCIDENCE OF CANCER TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE
    • FIGURE 19 SERVICES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN ANATOMIC PATHOLOGY MARKET
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE ANATOMIC PATHOLOGY MARKET
    • FIGURE 20 COUNTRIES IN THE ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 ANATOMIC PATHOLOGY MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS
    • 5.2.1 DRIVERS
      • 5.2.1.1 High incidence of cancer and other target diseases
    • TABLE 2 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
    • TABLE 3 PROJECTED INCREASE IN THE GLOBAL NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2035
      • 5.2.1.2 Recommendations for cancer screening
      • 5.2.1.3 Availability of reimbursement
      • 5.2.1.4 Growing focus on personalized medicine
    • TABLE 4 % OF PERSONALIZED MEDICINES IN OVERALL DRUG APPROVAL BY FDA, 2014 TO 2020
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Increasing number of clinical trials pertaining to cancer drugs
      • 5.2.2.2 Emerging markets offer lucrative opportunities
      • 5.2.2.3 Companion diagnostics
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Availability of refurbished products
      • 5.2.3.2 Lack of skilled professionals
    • TABLE 5 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
      • 5.2.3.3 Product failures and recalls
      • 5.2.3.4 Inadequate infrastructure and low awareness in middle- and low-income countries
    • 5.2.4 TRENDS
      • 5.2.4.1 Reagent rental agreements
    • 5.2.5 IMPACT OF COVID-19 ON THE ANATOMIC PATHOLOGY MARKET
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 RANGES/SCENARIOS
    • 5.4.1 ANATOMIC PATHOLOGY MARKET
    • FIGURE 22 PESSIMISTIC SCENARIO
    • FIGURE 23 OPTIMISTIC SCENARIO
    • FIGURE 24 REALISTIC SCENARIO
  • 5.5 PRICING ANALYSIS
    • TABLE 6 PRICES OF ANATOMIC PATHOLOGY PRODUCTS
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 25 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 26 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.8 ECOSYSTEM ANALYSIS
    • 5.8.1 ROLE IN THE ECOSYSTEM
    • FIGURE 27 KEY PLAYERS IN THE ANATOMIC PATHOLOGY ECOSYSTEM
  • 5.9 TECHNOLOGY ANALYSIS
    • TABLE 7 TECHNOLOGICAL ADVANCEMENT IN THE ANATOMIC PATHOLOGY MARKET (2018-2021)
  • 5.10 REGULATORY LANDSCAPE
    • FIGURE 28 510(K) APPROVAL PROCESS
  • 5.11 PATENT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • 5.12.1 TRADE ANALYSIS FOR TISSUE PROCESSING SYSTEMS
    • TABLE 8 IMPORT DATA FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 9 EXPORT DATA FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.13 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 10 PORTER'S FIVE FORCES ANALYSIS (2020): ANATOMIC PATHOLOGY MARKET
    • 5.13.1 THREAT OF NEW ENTRANTS
    • 5.13.2 INTENSITY OF COMPETITIVE RIVALRY
    • 5.13.3 BARGAINING POWER OF BUYERS
    • 5.13.4 BARGAINING POWER OF SUPPLIERS
    • 5.13.5 THREAT OF SUBSTITUTES

6 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 11 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 12 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • 6.1.1 PRIMARY NOTES
      • 6.1.1.1 Key industry insights
  • 6.2 SERVICES
    • TABLE 13 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 14 ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • 6.2.1 HISTOPATHOLOGY SERVICES
      • 6.2.1.1 Rising incidence of cancer is a key factor driving market growth
    • FIGURE 29 STEPS IN HISTOPATHOLOGY SLIDE PREPARATION
    • TABLE 15 HISTOPATHOLOGY SERVICES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 16 HISTOPATHOLOGY SERVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.2.2 CYTOPATHOLOGY SERVICES
      • 6.2.2.1 Government focus on cervical cancer screening has boosted the growth of the cytopathology services market
    • TABLE 17 CYTOPATHOLOGY SERVICES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 18 CYTOPATHOLOGY SERVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 6.3 CONSUMABLES
    • TABLE 19 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 20 ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • 6.3.1 ANTIBODIES
    • TABLE 21 ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 22 ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
      • 6.3.1.1 Primary antibodies
        • 6.3.1.1.1 High specificity and accuracy of primary antibodies to drive the market
    • TABLE 23 PRIMARY ANTIBODIES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 24 PRIMARY ANTIBODIES MARKET, BY REGION, 2021-2026 (USD MILLION)
      • 6.3.1.2 Secondary antibodies
        • 6.3.1.2.1 Versatility of secondary antibodies ensuring their stable demand among end users
    • TABLE 25 SECONDARY ANTIBODIES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 26 SECONDARY ANTIBODIES MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.3.2 KITS & REAGENTS
    • TABLE 27 KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 28 KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
      • 6.3.2.1 Stains & solvents
        • 6.3.2.1.1 Introduction of automation can limit the market growth
    • TABLE 29 STAINS & SOLVENTS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 30 STAINS & SOLVENTS MARKET, BY REGION, 2021-2026 (USD MILLION)
      • 6.3.2.2 Fixatives
        • 6.3.2.2.1 Adoption of non-toxic fixatives to drive market growth
    • TABLE 31 FIXATIVES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 32 FIXATIVES MARKET, BY REGION, 2021-2026 (USD MILLION)
      • 6.3.2.3 Other kits & reagents
    • TABLE 33 OTHER KITS & REAGENTS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 34 OTHER KITS & REAGENTS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.3.3 PROBES
      • 6.3.3.1 Increasing research to aid the market growth
    • TABLE 35 PROBES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 36 PROBES MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.3.4 OTHER CONSUMABLES
    • TABLE 37 OTHER CONSUMABLES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 38 OTHER CONSUMABLES MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 6.4 INSTRUMENTS
    • TABLE 39 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 40 ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • 6.4.1 SLIDE STAINING SYSTEMS
      • 6.4.1.1 Availability of automated systems will drive market growth during the forecast period
    • TABLE 41 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 42 SLIDE STAINING SYSTEMS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.4.2 TISSUE PROCESSING SYSTEMS
      • 6.4.2.1 Rising adoption of automation is a key trend in the tissue processing systems market
    • TABLE 43 TISSUE PROCESSING SYSTEMS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 44 TISSUE PROCESSING SYSTEMS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.4.3 CELL PROCESSORS
      • 6.4.3.1 Cell processors are used to remove unwanted matter in samples-making them important instruments in the market
    • TABLE 45 CELL PROCESSORS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 46 CELL PROCESSORS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.4.4 MICROTOMES
      • 6.4.4.1 Rotary microtomes are the most commonly used microtomes
    • TABLE 47 MICROTOMES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 48 MICROTOMES MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.4.5 EMBEDDING SYSTEMS
      • 6.4.5.1 Liquid paraffin is the most commonly used embedding medium
    • TABLE 49 EMBEDDING SYSTEMS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 50 EMBEDDING SYSTEMS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.4.6 COVERSLIPPERS
      • 6.4.6.1 Coverslippers are widely used instruments in research
    • TABLE 51 COVERSLIPPERS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 52 COVERSLIPPERS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • 6.4.7 OTHER INSTRUMENTS
    • TABLE 53 OTHER INSTRUMENTS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 54 OTHER INSTRUMENTS MARKET, BY REGION, 2021-2026 (USD MILLION)

7 ANATOMIC PATHOLOGY MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • 7.1.1 PRIMARY NOTES
      • 7.1.1.1 Key industry insights
    • TABLE 55 ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 56 ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
  • 7.2 DISEASE DIAGNOSTICS
    • TABLE 57 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2016-2020 (USD MILLION)
    • TABLE 58 ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2021-2026 (USD MILLION)
    • 7.2.1 CANCER
    • TABLE 59 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 60 ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
      • 7.2.1.1 Breast cancer
        • 7.2.1.1.1 Breast cancer accounts for the highest mortality rate among cancers in North America
    • TABLE 61 BREAST CANCER INCIDENCE, BY REGION, 2020 VS. 2040
    • TABLE 62 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 63 ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION, 2021-2026 (USD MILLION)
      • 7.2.1.2 Gastrointestinal cancer
        • 7.2.1.2.1 The rising incidence of gastric cancer will boost the market growth
    • TABLE 64 COLORECTAL CANCER INCIDENCE, BY REGION, 2020 VS. 2040
    • TABLE 65 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 66 ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2021-2026 (USD MILLION)
      • 7.2.1.3 Lung cancer
        • 7.2.1.3.1 Lung cancer is the most common cancer in the world
    • TABLE 67 LUNG CANCER INCIDENCE, BY REGION, 2020 VS. 2040
    • TABLE 68 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 69 ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION, 2021-2026 (USD MILLION)
      • 7.2.1.4 Prostate cancer
        • 7.2.1.4.1 Prostate cancers are prevalent in the geriatric male population
    • TABLE 70 PROSTATE CANCER INCIDENCE, BY REGION, 2020 VS. 2040
    • TABLE 71 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 72 ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2021-2026 (USD MILLION)
      • 7.2.1.5 Other cancers
    • TABLE 73 MELANOMA INCIDENCE, BY REGION, 2020 VS. 2040
    • TABLE 74 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCERS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 75 ANATOMIC PATHOLOGY MARKET FOR OTHER CANCERS, BY REGION, 2021-2026 (USD MILLION)
    • 7.2.2 OTHER DISEASES
    • TABLE 76 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 77 ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2021-2026 (USD MILLION)
  • 7.3 MEDICAL RESEARCH
    • 7.3.1 GROWING RESEARCH ACTIVITIES WILL DRIVE THE ADOPTION OF ANATOMIC PATHOLOGY PRODUCTS IN THIS APPLICATION SEGMENT
    • TABLE 78 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 79 ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2021-2026 (USD MILLION)

8 ANATOMIC PATHOLOGY MARKET, BY END USER

  • 8.1 INTRODUCTION
    • 8.1.1 PRIMARY NOTES
      • 8.1.1.1 Key industry insights
    • TABLE 80 ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 81 ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 8.2 HOSPITAL LABORATORIES
    • 8.2.1 HOSPITAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
    • TABLE 82 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 83 ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2021-2026 (USD MILLION)
  • 8.3 CLINICAL LABORATORIES
    • 8.3.1 INCREASING OUTPATIENT SURGERIES TO DRIVE THE GROWTH OF THIS SEGMENT
    • TABLE 84 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 85 ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021-2026 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 86 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 87 ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION, 2021-2026 (USD MILLION)

9 ANATOMIC PATHOLOGY MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 88 ANATOMIC PATHOLOGY MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 89 ANATOMIC PATHOLOGY MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012-2035
    • FIGURE 31 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET SNAPSHOT
    • TABLE 90 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 91 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 92 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 93 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 94 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 95 NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 96 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 97 NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 98 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 99 NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 100 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 101 NORTH AMERICA: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 102 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 103 NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 104 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 105 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 106 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 107 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 108 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 109 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 110 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 111 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominates the global anatomic pathology market
    • TABLE 112 US: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040
    • TABLE 113 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 114 US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 115 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 116 US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 117 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 118 US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 119 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 120 US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 121 US: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 122 US: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 123 US: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 124 US: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 125 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 126 US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 127 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 128 US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 129 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 130 US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 131 US: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 132 US: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 High burden of cancer to support market growth
    • TABLE 133 CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040
    • TABLE 134 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 135 CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 136 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 137 CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 138 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 139 CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 140 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 141 CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 142 CANADA: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 143 CANADA: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 144 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 145 CANADA: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 146 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 147 CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 148 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 149 CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 150 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 151 CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 152 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 153 CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 9.3 EUROPE
    • FIGURE 32 EUROPE: CANCER INCIDENCE & MORTALITY, 2012-2035
    • TABLE 154 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 155 EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 156 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 157 EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 158 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 159 EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 160 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 161 EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 162 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 163 EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 164 EUROPE: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 165 EUROPE: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 166 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 167 EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 168 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 169 EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 170 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 171 EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 172 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 173 EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 174 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 175 EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Availability of reimbursement for colorectal cancer screening to support market growth
    • TABLE 176 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040
    • TABLE 177 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 178 GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 179 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 180 GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 181 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 182 GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 183 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 184 GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 185 GERMANY: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 186 GERMANY: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 187 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 188 GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 189 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 190 GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 191 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 192 GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 193 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 194 GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 195 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 196 GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Government funding for cancer diagnosis & prevention to support market growth
    • TABLE 197 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040
    • TABLE 198 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 199 FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 200 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 201 FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 202 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 203 FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 204 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 205 FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 206 FRANCE: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 207 FRANCE: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 208 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 209 FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 210 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 211 FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 212 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 213 FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 214 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 215 FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 216 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 217 FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Government initiatives to drive market growth in the UK
    • TABLE 218 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 219 UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 220 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 221 UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 222 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 223 UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 224 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 225 UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 226 UK: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 227 UK: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 228 UK: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 229 UK: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 230 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 231 UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 232 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 233 UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 234 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 235 UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 236 UK: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 237 UK: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Growing geriatric population to support market growth in Italy
    • TABLE 238 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 239 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 240 ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 241 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 242 ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 243 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 244 ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 245 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 246 ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 247 ITALY: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 248 ITALY: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 249 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 250 ITALY: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 251 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 252 ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 253 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 254 ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 255 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 256 ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 257 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 258 ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 High incidence of chronic diseases to drive the Spanish market
    • TABLE 259 SPAIN: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 260 SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 261 SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 262 SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 263 SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 264 SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 265 SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 266 SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 267 SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 268 SPAIN: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 269 SPAIN: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 270 SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 271 SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 272 SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 273 SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 274 SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 275 SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 276 SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 277 SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 278 SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 279 SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 280 ROE: CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040
    • TABLE 281 ROE: LUNG CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040
    • TABLE 282 ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 283 ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 284 ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 285 ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 286 ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 287 ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 288 ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 289 ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 290 ROE: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 291 ROE: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 292 ROE: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 293 ROE: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 294 ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 295 ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 296 ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 297 ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 298 ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 299 ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 300 ROE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 301 ROE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 33 ASIA PACIFIC: CANCER INCIDENCE & MORTALITY, 2012-2035
    • FIGURE 34 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET SNAPSHOT
    • TABLE 302 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 303 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 304 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 305 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 306 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 307 ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 308 ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 309 ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 310 ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 311 ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 312 ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 313 ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 314 ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 315 ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 316 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 317 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 318 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 319 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 320 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 321 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 322 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 323 ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Presence of a well-developed healthcare system to support market growth in Japan
    • TABLE 324 JAPAN: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040
    • TABLE 325 JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 326 JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 327 JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 328 JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 329 JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 330 JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 331 JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 332 JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 333 JAPAN: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 334 JAPAN: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 335 JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 336 JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 337 JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 338 JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 339 JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 340 JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 341 JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 342 JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 343 JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 344 JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 High investments in R&D to drive the market growth
    • TABLE 345 CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 346 CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 347 CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 348 CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 349 CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 350 CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 351 CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 352 CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 353 CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 354 CHINA: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 355 CHINA: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 356 CHINA: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 357 CHINA: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 358 CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 359 CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 360 CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 361 CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 362 CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 363 CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 364 CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 365 CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Expanding healthcare sector in the country to drive market growth
    • TABLE 366 INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 367 INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 368 INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 369 INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 370 INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 371 INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 372 INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 373 INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 374 INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 375 INDIA: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 376 INDIA: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 377 INDIA: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 378 INDIA: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 379 INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 380 INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 381 INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 382 INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 383 INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 384 INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 385 INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 386 INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 387 ROAPAC: INCIDENCE OF CANCER, BY COUNTRY, 2020 VS. 2040
    • TABLE 388 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 389 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 390 ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 391 ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 392 ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 393 ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 394 ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 395 ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 396 ROAPAC: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 397 ROAPAC: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 398 ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 399 ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 400 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 401 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 402 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 403 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 404 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 405 ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 406 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 407 ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • TABLE 408 ROW: ANATOMIC PATHOLOGY MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 409 ROW: ANATOMIC PATHOLOGY MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 410 ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 411 ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 412 ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 413 ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 414 ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 415 ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 416 ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 417 ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 418 ROW: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 419 ROW: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 420 ROW: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 421 ROW: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 422 ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 423 ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 424 ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 425 ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 426 ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 427 ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 428 ROW: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 429 ROW: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.5.1 LATIN AMERICA
      • 9.5.1.1 Cancer screening programs to support market growth
    • TABLE 430 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
    • TABLE 431 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
    • TABLE 432 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
    • TABLE 433 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 434 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 435 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 436 LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 437 LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 438 LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 439 LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 440 LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 441 LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 442 LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 443 LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 444 LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 445 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 446 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 447 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 448 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 449 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 450 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 451 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 452 LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 9.5.2 MIDDLE EAST & AFRICA
      • 9.5.2.1 Increasing incidence of cancer in Africa to support market growth
    • TABLE 453 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
    • TABLE 454 MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 455 MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 456 MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 457 MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 458 MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 459 MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 460 MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 461 MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 462 MEA: ANTIBODIES MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 463 MEA: ANTIBODIES MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 464 MEA: KITS & REAGENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 465 MEA: KITS & REAGENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 466 MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 467 MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 468 MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016-2020 (USD MILLION)
    • TABLE 469 MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021-2026 (USD MILLION)
    • TABLE 470 MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 471 MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 472 MEA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 473 MEA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2021-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 474 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS
  • 10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (INSTRUMENTS AND CONSUMABLES)
    • FIGURE 35 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ANATOMIC PATHOLOGY MARKET (INSTRUMENTS AND CONSUMABLES)
  • 10.4 MARKET SHARE ANALYSIS (INSTRUMENTS AND CONSUMABLES)
    • FIGURE 36 ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, 2020 (INSTRUMENTS AND CONSUMABLES)
    • TABLE 475 ANATOMIC PATHOLOGY MARKET (INSTRUMENTS AND CONSUMABLES): DEGREE OF COMPETITION (2020)
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 37 ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 10.6 COMPANY EVALUATION QUADRANT: SMES/START-UPS
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 38 ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS, 2020
  • 10.7 COMPETITIVE SCENARIO
    • 10.7.1 PRODUCT LAUNCHES
    • TABLE 476 KEY PRODUCT LAUNCHES
    • 10.7.2 DEALS
    • TABLE 477 KEY DEALS
    • 10.7.3 OTHER DEVELOPMENTS
    • TABLE 478 OTHER KEY DEVELOPMENTS
  • 10.8 COMPETITIVE BENCHMARKING
    • 10.8.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS
    • TABLE 479 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE ANATOMIC PATHOLOGY MARKET FOR INSTRUMENTS AND CONSUMABLES
    • TABLE 480 PRODUCT FOOTPRINT OF COMPANIES
    • TABLE 481 REGIONAL FOOTPRINT OF COMPANIES

11 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 11.1 KEY PLAYERS
    • 11.1.1 F. HOFFMAN-LA ROCHE LTD.
    • TABLE 482 F. HOFFMAN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 39 COMPANY SNAPSHOT: F. HOFFMAN-LA ROCHE LTD. (2020)
    • 11.1.2 DANAHER CORPORATION
    • TABLE 483 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 40 COMPANY SNAPSHOT: DANAHER (2020)
    • 11.1.3 PHC HOLDINGS CORPORATION
    • TABLE 484 PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW
    • 11.1.4 ABCAM PLC.
    • TABLE 485 ABCAM PLC.: BUSINESS OVERVIEW
    • FIGURE 41 COMPANY SNAPSHOT: ABCAM PLC. (2020)
    • 11.1.5 HOLOGIC, INC.
    • TABLE 486 HOLOGIC, INC.: BUSINESS OVERVIEW
    • FIGURE 42 COMPANY SNAPSHOT: HOLOGIC, INC. (2020)
    • 11.1.6 AGILENT TECHNOLOGIES
    • TABLE 487 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 43 COMPANY SNAPSHOT: AGILENT TECHNOLOGIES (2020)
    • 11.1.7 BECTON, DICKINSON AND COMPANY
    • TABLE 488 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 44 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020)
    • 11.1.8 SAKURA FINETEK USA INC.
    • TABLE 489 SAKURA FINETEK: BUSINESS OVERVIEW
    • 11.1.9 MERCK KGAA
    • TABLE 490 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 45 COMPANY SNAPSHOT: MERCK KGAA (2020)
    • 11.1.10 BIO SB
    • TABLE 491 BIO SB: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 BIOGENEX
    • 11.2.2 MILESTONE MEDICAL
    • 11.2.3 HISTO-LINE LABORATORIES
    • 11.2.4 DIAPATH S.P.A.
    • 11.2.5 SLEE MEDICAL GMBH
    • 11.2.6 AMOS SCIENTIFIC PTY LTD.
    • 11.2.7 MEDITE MEDICAL GMBH
    • 11.2.8 CELL SIGNALING TECHNOLOGY
    • 11.2.9 CELLPATH LTD.
    • 11.2.10 JINHUA YIDI MEDICAL APPLIANCE CO. LTD.
    • 11.2.11 MICROS AUSTRIA
    • 11.2.12 R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED
    • 11.2.13 LUPETEC
    • 11.2.14 MEDIMEAS
    • 11.2.15 BRIGHT INSTRUMENTS
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS